Report Update Nov 1, 2024

Scandinavia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Scandinavia: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Scandinavia

The Scandinavia medicaments containing insulin market shrank sharply to $X in 2021, reducing by -53.8% against the previous year. Over the period under review, consumption, however, recorded significant growth. As a result, consumption reached the peak level of $X, and then declined dramatically in the following year.

Medicaments Containing Insulin Production in Scandinavia

In value terms, medicaments containing insulin production rose slightly to $X in 2021 estimated in export price. Overall, production, however, continues to indicate a perceptible setback. Over the period under review, production hit record highs at $X in 2013; however, from 2014 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in Scandinavia

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were exported in Scandinavia; waning by -52.2% against the previous year. Overall, exports recorded a sharp reduction. The most prominent rate of growth was recorded in 2019 with an increase of 297% against the previous year. As a result, the exports attained the peak of X tons. From 2020 to 2021, the growth of the exports remained at a somewhat lower figure.

In value terms, medicaments containing insulin exports dropped dramatically to $X in 2021. Over the period under review, exports faced a precipitous descent. The growth pace was the most rapid in 2019 when exports increased by 58%. Over the period under review, the exports hit record highs at $X in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

In 2021, Denmark (X tons) represented the key exporter of medicaments containing insulin but not antibiotics, achieving 83% of total exports. It was distantly followed by Norway (X tons), generating a 17% share of total exports.

From 2012 to 2021, average annual rates of growth with regard to medicaments containing insulin exports from Denmark stood at -24.5%. Norway experienced a relatively flat trend pattern. While the share of Norway (+17 p.p.) increased significantly in terms of the total exports from 2012-2021, the share of Denmark (-16.8 p.p.) displayed negative dynamics.

In value terms, Denmark ($X) remains the largest medicaments containing insulin supplier in Scandinavia, comprising 75% of total exports. The second position in the ranking was held by Norway ($X), with a 24% share of total exports.

In Denmark, medicaments containing insulin exports shrank by an average annual rate of -36.9% over the period from 2012-2021.

Export Prices by Country

In 2021, the export price in Scandinavia amounted to $X per ton, increasing by 15% against the previous year. In general, the export price, however, faced a deep slump. Over the period under review, the export prices reached the peak figure at $X per ton in 2013; however, from 2014 to 2021, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was Norway ($X per ton), while Denmark stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Denmark (-16.4%).

Medicaments Containing Insulin Imports

Imports in Scandinavia

In 2021, after two years of growth, there was significant decline in overseas purchases of medicaments containing insulin but not antibiotics, when their volume decreased by -60.6% to X tons. Over the period under review, imports, however, posted significant growth. The growth pace was the most rapid in 2013 when imports increased by 2,977%. Over the period under review, imports attained the maximum at X tons in 2020, and then declined rapidly in the following year.

In value terms, medicaments containing insulin imports fell to $X in 2021. Overall, imports, however, enjoyed significant growth. The most prominent rate of growth was recorded in 2013 with an increase of 8,908% against the previous year. Over the period under review, imports reached the peak figure at $X in 2020, and then reduced in the following year.

Imports by Country

Denmark (X tons) represented roughly 99.9% of total imports in 2021.

Denmark was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +27.5% from 2012 to 2021. While the share of Denmark (+99 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Scandinavia.

In Denmark, medicaments containing insulin imports increased at an average annual rate of +20.7% over the period from 2012-2021.

Import Prices by Country

In 2021, the import price in Scandinavia amounted to $X per ton, picking up by 120% against the previous year. Overall, the import price showed a remarkable increase. The most prominent rate of growth was recorded in 2016 an increase of 297%. Over the period under review, import prices hit record highs at $X per ton in 2013; however, from 2014 to 2021, import prices failed to regain momentum.

As there is only one major supplying country, the average price level is determined by prices for Denmark.

From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to -5.3% per year.

Source: IndexBox Platform

This report provides an in-depth analysis of the medicaments containing insulin market in Scandinavia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Production in Scandinavia, split by region and country
Trade (exports and imports) in Scandinavia
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. CONSUMPTION BY COUNTRY
3. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
2. PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
11. COUNTRY PROFILES

The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO
- Finland
- Norway
- Sweden
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption, By Country, 2018–2023
5. Production, In Physical Terms, By Country, 2012–2023
6. Imports, In Physical Terms, By Country, 2012–2023
7. Imports, In Value Terms, By Country, 2012–2023
8. Import Prices, By Country Of Destination, 2012–2023
9. Exports, In Physical Terms, By Country, 2012–2023
10. Exports, In Value Terms, By Country, 2012–2023
11. Export Prices, By Country Of Origin, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Consumption, By Country, 2023
4. Market Volume Forecast to 2030
5. Market Value Forecast to 2030
6. Products: Market Size And Growth, By Type
7. Products: Average Per Capita Consumption, By Type
8. Products: Exports And Growth, By Type
9. Products: Export Prices And Growth, By Type
10. Production Volume And Growth
11. Exports And Growth
12. Export Prices And Growth
13. Market Size And Growth
14. Per Capita Consumption
15. Imports And Growth
16. Import Prices
17. Production, In Physical Terms, 2012–2023
18. Production, In Value Terms, 2012–2023
19. Production, By Country, 2023
20. Production, In Physical Terms, By Country, 2012–2023
21. Imports, In Physical Terms, 2012–2023
22. Imports, In Value Terms, 2012–2023
23. Imports, In Physical Terms, By Country, 2023
24. Imports, In Physical Terms, By Country, 2012–2023
25. Imports, In Value Terms, By Country, 2012–2023
26. Import Prices, By Country, 2012–2023
27. Exports, In Physical Terms, 2012–2023
28. Exports, In Value Terms, 2012–2023
29. Exports, In Physical Terms, By Country, 2023
30. Exports, In Physical Terms, By Country, 2012–2023
31. Exports, In Value Terms, By Country, 2012–2023
32. Export Prices, 2012–2023